LBO — METHODIST MIDLOTHIAN MEDICAL CENTER
IRR: 29.8% | MOIC: 3.68x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
29.8%
IRR
3.68x
MOIC
$19.4M
Entry EV
$46.2M
Exit EV
$10.0M
Equity Invested
Sources & Uses
S&UTotal · $19.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $7.5M | 38.8% | |
| Sub Debt | $1.9M | 9.7% | |
| Equity | $10.0M | 51.5% | |
| Enterprise Value | $18.9M | 97.1% | |
| Transaction Fees | $0.6M | 2.9% | |
| Total Uses | $19.4M | 100.0% |
Interpretation
INTAt 3.68x MOIC and 29.8% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $4.4M |
| Exit Ev | $46.2M |
| Net Debt At Exit | $9.4M |
| Equity At Exit | $36.8M |
| Equity Invested | $10.0M |
| Total Value Created | $26.8M |
| Value From Growth | $26.4M |
| Value From Multiple | $0.9M |
| Value From Deleveraging | $0.0M |